TrialThe Journal of clinical investigation2017

Ultrasensitive mutation detection identifies rare residual cells causing acute myelogenous leukemia relapse.

Brian Parkin et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.